TIDMAPH

RNS Number : 7423A

Alliance Pharma PLC

02 January 2018

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Total Voting Rights

Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, makes the following notification in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1.

As at 29 December 2017 the Company's issued share capital consists of 474,989,998 Ordinary Shares of 1p each.

The total number of voting rights in the Company is 474,989,998 and this figure may be used by shareholders as the denominator for the calculations by which they should determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information:

 
 Alliance Pharma plc                           + 44 (0) 1249 466966 
 John Dawson, Chief Executive 
  Officer 
  Peter Butterfield, Deputy 
  Chief Executive Officer 
  Andrew Franklin, Chief 
  Financial Officer 
 www.alliancepharma.co.uk 
 
   Buchanan                                   + 44 (0) 20 7466 5000 
 Mark Court / Sophie Cowles 
 
 Numis Securities Limited                     + 44 (0) 20 7260 1000 
 Nominated Adviser: Michael 
  Meade / Freddie Barnfield 
 Corporate Broking: James 
  Black / Toby Adcock 
 
 Investec Bank plc                             +44 (0) 20 7597 5970 
 Corporate Finance: Daniel 
  Adams / Ed Thomas 
  Corporate Broking: Patrick 
  Robb / Rob Baker

Notes to editors:

About Alliance Pharma

Alliance, founded in 1998, is an international speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has sales in more than 100 countries worldwide via direct sales, joint ventures and a network of distributors. Alliance has a strong track record of acquiring the rights to established niche products and it currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The Company continues to explore opportunities to expand its product portfolio.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVRUGUCAGUPRGWP

(END) Dow Jones Newswires

January 02, 2018 09:00 ET (14:00 GMT)

Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Alliance Pharma Charts.
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Alliance Pharma Charts.